Age, education predict effective cataract surgery coverage

Age and education level are significantly related to the odds of undergoing cataract surgery and achieving a good visual outcome, according to a study published in BioMed Research International.
The finding came from an analysis of how many people in a Chinese population had “effective cataract surgery coverage.”
“The cataract surgical coverage metric ... quantifies the proportion of individuals within a population who have undergone or are in need of cataract surgery,” Qinrui Hu, of Xiamen Eye Center of Xiamen University, China, and colleagues wrote. “Effective

Exercise, ibuprofen reduce cancer-related cognitive impairment

Exercise and low-dose ibuprofen may help improve some aspects of cognitive function for people with cancer undergoing chemotherapy, according to results of a randomized phase 2 trial.
The benefits with ibuprofen appeared less robust and consistent than those observed with exercise, underscoring the need for additional research to better understand its effects.
“There are already published guidelines that recommend exercise for people undergoing cancer treatment, as well as for survivors, but this is one of the first trials I am aware of to look at an anti-inflammatory medication — specifically

Extensively drug-resistant Shigella on rise in US

Extensively drug-resistant Shigella is on the rise in the United States, according to data published by the CDC.
Shigella is a bacterium that can be sexually transmitted and causes infectious diarrhea. The new study published in MMWR found that among nearly 17,000 Shigella isolates submitted to a CDC surveillance network, the proportion of extensively drug-resistant (XDR) isolates rose from 0% in 2011 to 8.5% in 2023. Around one-third of patients with XDR Shigella ended up hospitalized.
The report mentioned that XDR Shigella spreads easily from person-to-person through fecal-oral contact or

Acupuncture may improve pain, reduce opioid use after THA

Acupuncture performed during total hip arthroplasty as part of an enhanced recovery after surgery protocol may improve immediate postoperative pain and reduce early opioid use, according to results.
“This is something that is very, very safe,” Stephanie I. Cheng, MD, DABMA, FAAMA, from Hospital for Special Surgery, told Healio about results presented at the American Academy of Medical Acupuncture (AAMA) Annual Symposium and which was awarded first place in the AAMA annual research paper competition. “The safety profile is good. It is performed on the ear, it is away from the surgical site and

Violet light filtering IOL shows tolerance to induced astigmatism

A full visual range IOL with violet light filtering showed good tolerance to induced astigmatism in patients corrected for distance vision, according to a study published in Journal of Refractive Surgery.
Hugo T. F. Borges, MD, and colleagues wrote that previous research has shown that IOLs can enhance contrast sensitivity by filtering high-energy violet light, which reduces scatter as well as dysphotopsias. They wanted to find out how the IOL under study might interact with residual refractive error.
“The increasing demand for high-quality visual outcomes is driven by patients’ elevated

FDA approves automated insulin delivery system for pregnancy

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry press release.
The Control-IQ+ automated insulin delivery system (Tandem Diabetes Care) is the first automated insulin delivery system approved by the FDA to be used during pregnancy for women with type 1 diabetes, according to the company. The FDA approved the system for use with Tandem’s t:slim X2 and Mobi insulin pumps.
The clearance was granted based on findings from the CIRCUIT trial. As Healio previously reported from the American Diabetes Association Scientific

Reconsider when children start playing tackle football

Recent data confirms what many pediatricians have long suspected: American football accounts for nearly one-fifth of all youth traumatic brain injuries, making it the single largest contributor to sports-related TBIs in children.
As physicians entrusted with protecting our youngest patients, we can no longer ignore the mounting evidence that early exposure to tackle football poses unacceptable risks to developing brains.
The numbers are sobering. Between 2010 and 2016, an average of 283,000 children aged younger than 18 years sought ED care annually for sports and recreation-related TBIs, with

New AAD leaders aim to fix ‘broken’ access to care, serve next generation of dermatologists

The newly elected leadership for the American Academy of Dermatology intends to address the primary issues that plague dermatologists today, including low reimbursement and limited resources.
At the American Academy of Dermatology Annual Meeting, Murad Alam, MD, MBA, MSCI, FAAD, vice chair of the department of dermatology and professor at Northwestern University Feinberg School of Medicine, assumed his 1-year term as president of the AAD. His successor, Andrew H. Weinstein, MD, MPH, FAAD, dermatologist and Mohs surgeon in Boynton Beach, Fla., and associate volunteer professor at University of

Apple Watch can capture arrhythmias in children

The Apple Watch captured true arrhythmia events in children more frequently than standard patch monitoring, according to results of the Pediatric Apple Watch Study presented at Heart Rhythm 2026.
“After the Apple Heart Study was published, we started to see a lot of pediatric patients come into our pediatric cardiology clinics having used their Apple Watch for arrhythmia detection,” Scott R. Ceresnak, MD, professor of pediatrics (cardiology) at Stanford University School of Medicine, who presented the findings, told Healio. “We published a paper a few years back doing a retrospective analysis

Weekly growth hormone therapy improves body composition in adults

LAS VEGAS — A once-weekly therapy to treat growth hormone deficiency was well tolerated and conferred improvements in multiple body composition measures at 1 year, according to long-term extension trial data.
In July 2025, Ascendis Pharma announced that, based on data from the phase 3 foresiGHt trial, the FDA approved once-weekly lonapegsomatropin-tcgd (Skytrofa, Ascendis Pharma) as a therapy to replace endogenous GH for adults with GH deficiency. During a presentation at the American Association of Clinical Endocrinology Annual Scientific and Clinical Conference, Julie M. Silverstein, MD,